The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 11, 2016
Filed:
Jun. 22, 2015
Applicants:
Sbi Pharmaceuticals Co., Ltd., Tokyo, JP;
The University of Tokyo, Tokyo, JP;
Inventors:
Tohru Tanaka, Tokyo, JP;
Satofumi Kawata, Tokyo, JP;
Takeo Kohda, Tokyo, JP;
Motowo Nakajima, Tokyo, JP;
Kiyoshi Kita, Tokyo, JP;
Assignees:
SBI Pharmaceuticals Co., Ltd., Tokyo, JP;
The University of Tokyo, Tokyo, JP;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/197 (2006.01); A61K 45/06 (2006.01); A61K 31/221 (2006.01); A61K 33/06 (2006.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/197 (2013.01); A61K 9/4866 (2013.01); A61K 31/221 (2013.01); A61K 33/06 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 45/06 (2013.01);
Abstract
Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains, as an active ingredient, 5-aminolevulinic acid (ALA), a derivative thereof, or a pharmacologically acceptable salt thereof, is used.